Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06351865

Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent

Patient report complication data to our best knowledge has not been studied yet in electronic consent. This study is a feasibility study to assess whether patients will reliably report their complications, the quality of this reporting and whether the information provided in the consent form matches up to their experience. This data will then be used to improve the consent process and evaluate whether the Patient Initiated Follow Up (PIFU) model is effective or if it leads to underreporting of problems.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Queen Alexandra Hospital

Portsmouth, Hampshire, PO6 3LY, United Kingdom

Location status: Recruiting

Location contact

Edward St John

CONTACT

[email protected]

02392286000

About this study

At the time of consent, patients are informed of possible post-operative complications. It is often not known whether these complications actually occur, whether there are others which go unreported and the extent, both quantitatively and qualitatively, of the complications. Patient reported complication data, to our best knowledge has not been previously studied.

This study is a feasibility study to assess whether patients will reliably report their complications, the quality of this reporting and whether the information provided in the consent form matches up to their experience. In this case, consent is to be sought digitally; the digital consent form includes a procedure specific list of recognised complications but these might not reflect actual patient experience.

If PRC data collection is feasible and reliable, this technique could be scaled to create a consent feedback loop, enabling operative outcome data to be collected from all patients, to be be used to improve the consent process for subsequent patients.

Awareness of post-operative patient complications is important and it is an NHS (National Health Service) requirement that complications are discussed within regular clinical governance (mortality/morbidity) audit departmental meetings. Currently this process relies on clinicians obtaining and reporting these complications. The move towards Patient Initiated Follow Up (PIFU) models may be leading to underreporting of problems. Potentially Patient Reported Complications would allow for a more comprehensive understanding of the benefits and consequences of the various surgical procedures. This in turn might help facilitate 'shared decision making' and allow treatment decisions to be tailored to the individual patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consent form 1- Adult patients who have the capacity to consent for themselves.
  • Female adult aged 18years or above
  • Diagnosed with early invasive breast cancer suitable for breast conserving surgery
  • Undergoing Wide Local Excision of the breast and sentinel lymph node biopsy.
  • Participant must be able to fill out an electronic questionnaire or take part in a phone questionnaire.
  • Participant is willing and able to give informed consent for participation in the study.

Exclusion criteria

  • Unable to consent for themselves or do not wish to participate.
  • Patients who need an interpreter.

Treatment and study plan

Primary outcomes

  1. Proportion of patients who respond to the feedback questionnaire

    Time frame: 6 months

    Calculate the proportion of patients who respond to the feedback questionnaire

  2. Final attrition rate

    Time frame: 6 months

    Calculate the final attrition rate. This is the proportion of patients who fail to respond to the email questionnaire and telephone call.

Secondary outcomes

  1. Quoted risks in the consent to the incidence of complications

    Time frame: 6 months

    Compare the quoted risks in the consent to the incidence of complications reported by the patients.

  2. Frequency of PRC and CRCs (Consent Form Reported Complications)

    Time frame: 6 months

    Review the monthly department CGM (Clinical Governance Meeting) data for the study period and correlate the frequency of PRC and CRCs.

  3. Understanding of consent

    Time frame: 6 months

    Calculate the proportion of patients that feedback that they have understood the consent form.

  4. Language used in patient reported complications

    Time frame: 6 months

    Examine the language used by patients in the free-text box for reporting complications and whether this matches to that use in their consent form.

  5. Accuracy of potential complications

    Time frame: 6 months

    To examine the feedback from the patient questionnaire which asks, if they experienced a complication, was it mentioned as a possibility in their consent form.

  6. Participant preparation for surgery

    Time frame: 6 months

    From the feedback from the patient questionnaire, do patients feel fully informed about the procedure they are undertaking and feel well prepared

Study contacts

Contact information is provided by the study sponsor or research team.

Ian Gedge

CONTACT

[email protected]

02392286000 ext. 5153

Sponsors and collaborators

Lead sponsor

Portsmouth Hospitals NHS Trust

Other Gov

Collaborators

  • University of East Anglia

Registry information

Official study title

A Feasibility Study to Evaluate if Breast Cancer Patients, Consented Using Digital Consent, Reliably Provide Accurate Patient Reported Complication (PRC) Data Using Feedback Questionnaires

Acronym: PRC

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 8, 2024
Registry last updated
Jul 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.